Cargando…
Biomarkers in Alzheimer's Disease: A Review
Alzheimer's disease is the most common form of dementia affecting millions of individuals worldwide. It is currently diagnosed only via clinical assessments and confirmed by postmortem brain pathology. The development of validated biomarkers for Alzheimer's disease is essential to improve...
Autores principales: | Chintamaneni, Meena, Bhaskar, Manju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395245/ https://www.ncbi.nlm.nih.gov/pubmed/22811931 http://dx.doi.org/10.5402/2012/984786 |
Ejemplares similares
-
Protein and Imaging Biomarkers in the Eye for Early Detection of Alzheimer’s Disease
por: Fereshetian, Shaunt, et al.
Publicado: (2021) -
A Review of Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Lee, Ni-Chung, et al.
Publicado: (2017) -
Biomarkers in Alzheimer’s disease
por: Janeiro, Manuel H., et al.
Publicado: (2020) -
Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease
por: Chintamaneni, Pavan Kumar, et al.
Publicado: (2021) -
Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review
por: Gleerup, Helena Sophia, et al.
Publicado: (2019)